Cargando…
Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis
Atopic dermatitis (AD) is a common inflammatory skin disorder that manifests as eczematous lesions, often associated with allergic rhinitis and asthma. Historically, moderate-to-severe disease has been managed with systemic immunosuppression, such as oral corticosteroids, which result in relapse and...
Autores principales: | Awosika, Olabola, Kim, Lori, Mazhar, Momina, Rengifo-Pardo, Monica, Ehrlich, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789047/ https://www.ncbi.nlm.nih.gov/pubmed/29416367 http://dx.doi.org/10.2147/CCID.S123329 |
Ejemplares similares
-
Review of applications of microneedling in dermatology
por: Iriarte, Christopher, et al.
Publicado: (2017) -
A case of eosinophilic annular erythema as a presenting sign for autoimmune hepatitis
por: Awosika, Olabola, et al.
Publicado: (2017) -
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023) -
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022) -
Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
por: Xu, Xinghua, et al.
Publicado: (2017)